Mario Cattabiani III, The Pitt News, recently reported on University of Pittsburgh’s first-ever Seed Grants. Pitt received 171 applications and from that group selected 23 projects for awards, granting a total of approximately $1 million. One project selected was submitted by McGowan Institute for Regenerative Medicine affiliated faculty member, Kurt Weiss, MD, Associate Professor of Orthopaedic Surgery in the University of Pittsburgh School of Medicine, Department of Orthopaedic Surgery, Division of Musculoskeletal Oncology, who received a $50,000 grant to fund the Pittsburgh Sarcoma Research Collaborative, or PSaRC — a project that will aim to develop new therapeutic strategies and eventually improve sarcoma patient care and outcomes.
Dr. Weiss said the Pitt Seed program will help Pitt establish itself as a leader in sarcoma research.
“The Pitt Seed grant will help us on our goal to make the University of Pittsburgh a destination center for excellence for sarcoma research and treatment,” Dr. Weiss said.
PSaRC is a multidisciplinary team of researchers and physicians which focuses on sarcomas — rare cancerous tumors that afflict both children and adults. Treatment strategies and resulting outcomes for adult and pediatric sarcoma patients have not changed in the last 30 years — making them especially dangerous.
Congratulations, Dr. Weiss!
Read more…